A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine

Vaccine

Volumn 31, Issue 52, 2013, Pages 6239-6246

  Kobayashi, Hirofumi ^a   Iwatsuki Horimoto, Kiyoko ^a   Kiso, Maki ^a   Uraki, Ryuta ^a   Ichiko, Yurie ^a   Takimoto, Toru ^b   Kawaoka, Yoshihiro ^a,c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Antibody; Hamster; Influenza virus; Mucosal immunity; Vaccine

Indexed keywords

HN PROTEIN; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; MEMBRANE ANTIGEN; PARAINFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HAMSTER; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LUNG LAVAGE; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANTIBODY; HAMSTER; INFLUENZA VIRUS; MUCOSAL IMMUNITY; VACCINE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; CRICETINAE; FEMALE; HN PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINES; MESOCRICETUS; ORTHOMYXOVIRIDAE; PARAINFLUENZA VACCINES; PARAINFLUENZA VIRUS 3, HUMAN; SERUM; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 84888434104     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.029     Document Type: Article

References (32)

1. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report Recommendations and Reports/Centers for Disease Control 2010, 59(RR-8):1-62.
2. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases 2012, 12(1):36-44.
3. Wright P.F., Cherry J.D., Foy H.M., Glezen W.P., Hall C.B., McIntosh K., et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children-a multicentered evaluation of dosage and safety. Review of Infectious Diseases 1983, 5(4):758-764.
4. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. Journal of Medical Virology 1985, 17(4):325-335.
5. Murphy B.R., Prince G.A., Collins P.L., Van Wyke Coelingh K., Olmsted R.A., Spriggs M.K., et al. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Research 1988, 11(1):1-15.
6. Weinberg G.A., Hall C.B., Iwane M.K., Poehling K.A., Edwards K.M., Griffin M.R., et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. Journal of Pediatrics 2009, 154(5):694-699.
7. Schmidt A.C., Schaap-Nutt A., Bartlett E.J., Schomacker H., Boonyaratanakornkit J., Karron R.A., et al. Progress in the development of human parainfluenza virus vaccines. Expert review of respiratory medicine 2011, 5(4):515-526.
8. Spriggs M.K., Murphy B.R., Prince G.A., Olmsted R.A., Collins P.L. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. Journal of Virology 1987, 61(11):3416-3423.
9. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. New England Journal of Medicine 2006, 355(1):31-40.
10. Ozawa M., Victor S.T., Taft A.S., Yamada S., Li C., Hatta M., et al. Replication-incompetent influenza A viruses that stably express a foreign gene. Journal of General Virology 2011, 92(12):2879-2888.
11. Victor S.T., Watanabe S., Katsura H., Ozawa M., Kawaoka Y. A replication-incompetent PB2-knockout influenza A virus vaccine vector. Journal of Virology 2012, 86(8):4123-4128.
12. Hatakeyama S., Sakai-Tagawa Y., Kiso M., Goto H., Kawakami C., Mitamura K., et al. Enhanced expression of an α2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. Journal of Clinical Microbiology 2005, 43(8):4139-4146.
13. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy of Sciences 1999, 96(16):9345-9350.
14. Muramoto Y., Takada A., Fujii K., Noda T., Iwatsuki-Horimoto K., Watanabe S., et al. Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. Journal of Virology 2006, 80(5):2318-2325.
15. Kida H., Brown L.E., Webster R.G. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 1982, 122(1):38-47.
16. WHO WHO manual on animal influenza diagnosis and surveillance 2002, World Health Organization, Geneva, Switzerland, Available from: http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf.
17. Fujii Y., Goto H., Watanabe T., Yoshida T., Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proceedings of the National Academy of Sciences 2003, 100(4):2002-2007.
18. Ray R., Glaze B.J., Compans R.W. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. Journal of Virology 1988, 62(3):783-787.
19. Ray R., Glaze B.J., Moldoveanu Z., Compans R.W. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. Journal of Infectious Diseases 1988, 157(4):648-654.
20. Ray R., Brown V.E., Compans R.W. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. Journal of Infectious Diseases 1985, 152(6):1219-1230.
21. Martínez-Sobrido L., García-Sastre A. Recombinant influenza virus vectors. Future Virology 2007, 2(4):401-416.
22. Halperin S.A., Smith B., Mabrouk T., Germain M., Trépanier P., Hassell T., et al. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine 2002, 20(7-8):1240-1247.
23. Hampson A.W. Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Annals-Academy of Medicine Singapore 2008, 37(6):510.
24. Robertson J.S., Nicolson C., Bootman J.S., Major D., Robertson E.W., Wood J.M. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. Journal of General Virology 1991, 72(11):2671-2677.
25. Katz J.M., Wang M., Webster R.G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. Journal of Virology 1990, 64(4):1808-1811.
26. ® (Novartis Vaccines). Expert Review of Vaccines 2009, 8(6):679-688.
27. HHS First U.S. cell-based flu vaccine plant set for dedication 2011, Available from: http://www.hhs.gov/news/press/res/12/20111212a.html [updated 12.12.11; cited 25.12.12].
28. FDA FDA approves first seasonal influenza vaccine manufactured using cell culture technology 2012, Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm328982.htm [updated 20.11.12; cited 25.12.12].
29. Friedewald W.F., Hook E.W. Influenza virus infection in the hamster: a study of inapparent virus infection and virus adaptation. Journal of Experimental Medicine 1948, 88(3):343-353.
30. Ali M.J., Teh C.Z., Jennings R., Potter C.W. Transmissibility of influenza viruses in hamsters. Archives of Virology 1982, 72(3):187-197.
31. Buthala D.A., Soret M.G. Parainfluenza type 3 virus infection in hamsters: virologic, serologic, and pathologic studies. Journal of Infectious Diseases 1964, 114(3):226-234.
32. Liu C., Sharp E., Collins J. Studies on the pathogenesis of parainfluenza type 3 virus infection in hamsters. Archiv für die Gesamte Virusforschung 1968, 24(3):203-219.